+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pregnancy urinary phthalate metabolite concentrations and gestational diabetes risk factors



Pregnancy urinary phthalate metabolite concentrations and gestational diabetes risk factors



Environment International 96: 118-126



Epidemiologic studies suggest phthalate metabolite concentrations are associated with type 2 diabetes. GDM is a strong risk factor for type 2 diabetes. Little is known about phthalates and GDM risk factors (i.e. 1st trimester body mass index (BMI), gestational weight gain (GWG), and 2nd trimester glucose levels). A total of 350 women participating in Lifecodes pregnancy cohort (Boston, MA), delivered at term and had pregnancy urinary phthalate metabolite concentrations. Nine specific gravity-adjusted urinary phthalate metabolites were evaluated. General linear regression was used to assess associations between quartiles of phthalate metabolites and continuous 1st trimester BMI and late 2nd trimester blood glucose. Linear mixed models were used for total GWG. Multivariable logistic regression was used for phthalate concentrations and categorized GWG and impaired glucose tolerance defined as glucose≥140mg/dL based on a 50-gram glucose load test. Models were adjusted for potential confounders. There were no associations between 1st trimester urinary phthalate metabolite concentrations and 1st trimester BMI. Mono-ethyl phthalate concentrations averaged across pregnancy were associated with a 2.17 increased odds of excessive GWG (95% CI: 0.98, 4.79). Second trimester mono-ethyl phthalate was associated with increased odds of impaired glucose tolerance (adj. OR: 7.18; 95% CI: 1.97, 26.15). A summary measure of di-2-ethylhexyl phthalate metabolite concentrations were inversely associated with impaired glucose tolerance (adj. OR: 0.25; adj. 95% CI: 0.08, 0.85). Higher exposure to mono-ethyl phthalate, a metabolite of the parent compound of di-ethyl phthalate, may be associated with excessive GWG and impaired glucose tolerance; higher di-2-ethylhexyl phthalate was associated with reduced odds of impaired glucose tolerance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058602759

Download citation: RISBibTeXText

PMID: 27649471

DOI: 10.1016/j.envint.2016.09.009


Related references

Variability of Urinary Phthalate Metabolite and Bisphenol A Concentrations before and during Pregnancy. Environmental Health Perspectives 120(5): 739-745, 2012

Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environmental Health Perspectives 120(5): 739-745, 2012

Urinary phthalate metabolite concentrations and maternal weight during early pregnancy. International Journal of Hygiene and Environmental Health 220(8): 1347-1355, 2017

Urinary phthalate metabolite concentrations and blood glucose levels during pregnancy. International Journal of Hygiene and Environmental Health 218(3): 324-330, 2015

Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy. Environment International 123: 588-596, 2019

Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001-2008. Environmental Health Perspectives 120(9): 1307-1313, 2013

Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. Environment International 70: 118-124, 2014

Urinary Concentrations of Bisphenol A and Phthalate Metabolites Measured during Pregnancy and Risk of Preeclampsia. Environmental Health Perspectives 124(10): 1651-1655, 2016

Serum Phthalate and Triclosan Levels Have Opposing Associations With Risk Factors for Gestational Diabetes Mellitus. Frontiers in Endocrinology 9: 99, 2018

Urinary microalbumin and alpha1-microglobulin Concentrations in pregnant women with insulin-dependent diabetes mellitus , gestational diabetes , and pregnancy induced hypertension. Nephrology Dialysis Transplantation 13(6): A76, 1998

Associations between mixtures of urinary phthalate metabolites with gestational age at delivery: a time to event analysis using summative phthalate risk scores. Environmental Health 17(1): 56, 2018

Gestational diabetes and gestational impaired glucose tolerance in 1653 teenage pregnancies: prevalence, risk factors and pregnancy outcomes. Journal of Pediatric and Adolescent Gynecology 24(2): 62-65, 2011

Association of urinary concentrations of phthalate metabolites with cardiometabolic risk factors and obesity in children and adolescents. Chemosphere 211: 547-556, 2018

First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clinical Endocrinology 69(3): 407-411, 2008

Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Research and Clinical Practice 70(2): 134-142, 2005